Full Answer
Cancer metastatic to bilateral adrenals; Cancer metastatic to right adrenal gland; Secondary malignant neoplasm of bilateral adrenal glands ICD-10-CM Diagnosis Code C79.72 [convert to ICD-9-CM] Secondary malignant neoplasm of left adrenal gland
Secondary malignant neoplasm of left adrenal gland. C79.72 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2020 edition of ICD-10-CM C79.72 became effective on October 1, 2019. This is the American ICD-10-CM version of C79.72 - other international versions of ICD-10 C79.72 may differ.
Lung Cancer: ICD-10-CM Coding. Coding example: A patient with cancer in the lower lobe of his left lung presents for lobectomy. Proper coding is: C34.32 Malignant neoplasm of lower lobe, left bronchus or lung.
ICD-10-CM Diagnosis Code C79.81 [convert to ICD-9-CM] Secondary malignant neoplasm of breast Cancer metastatic to bilateral breasts; Cancer metastatic to breast; Cancer metastatic to left breast; Cancer metastatic to right breast; Cancer of the breast, metastatic; Secondary malignant neoplasm of bilateral breasts
Secondary malignant neoplasm of unspecified adrenal gland C79. 70 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2022 edition of ICD-10-CM C79. 70 became effective on October 1, 2021.
If the site of the primary cancer is not documented, the coder will assign a code for the metastasis first, followed by C80. 1 malignant (primary) neoplasm, unspecified. For example, if the patient was being treated for metastatic bone cancer, but the primary malignancy site is not documented, assign C79. 51, C80.
Nonmalignant neoplasms of the lung are classified to code 212.3 for benign, 235.7 for uncertain behavior, and 239.1 for unspecified nature. If the lung cancer is considered a metastatic site—the cancer spread from another organ to the lung—code 197.0 is assigned.
Basic DifferencesMalignantSecondary or MetastaticLungC34.9C78.0
Metastatic cancer has the same name as the primary cancer. For example, breast cancer that spreads to the lung is called metastatic breast cancer, not lung cancer. It is treated as stage IV breast cancer, not as lung cancer.
ICD-10 code C78. 00 for Secondary malignant neoplasm of unspecified lung is a medical classification as listed by WHO under the range - Malignant neoplasms .
ICD-10 code Z51. 11 for Encounter for antineoplastic chemotherapy is a medical classification as listed by WHO under the range - Factors influencing health status and contact with health services .
C80. 1 - Malignant (primary) neoplasm, unspecified | ICD-10-CM.
C34. 90 - Malignant neoplasm of unspecified part of unspecified bronchus or lung | ICD-10-CM.
Lung metastases are cancerous tumors that start somewhere else in the body and spread to the lungs. This x-ray shows a single lesion (pulmonary nodule) in the upper right lung (seen as a light area on the left side of the picture).
90 Malignant neoplasm of unspecified part of unspecified bronchus or lung.
non-small cell lung cancer.
Listen to pronunciation. (meh-TAS-tuh-sis) The spread of cancer cells from the place where they first formed to another part of the body. In metastasis, cancer cells break away from the original (primary) tumor, travel through the blood or lymph system, and form a new tumor in other organs or tissues of the body.
Squamous cell carcinoma of skin, unspecified C44. 92 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2022 edition of ICD-10-CM C44. 92 became effective on October 1, 2021.
C61 Malignant neoplasm of prostate.
Cancer of the lung, squamous cell, stage 1. Cancer of the lung, squamous cell, stage 2. Cancer of the lung, squamous cell, stage 3. Cancer of the lung, squamous cell, stage 4. Cancer, lung, non small cell. Eaton-lambert syndrome due to small cell carcinoma of lung. Eaton-lambert syndrome due to small cell lung cancer.
A primary malignant neoplasm that overlaps two or more contiguous (next to each other) sites should be classified to the subcategory/code .8 ('overlapping lesion'), unless the combination is specifically indexed elsewhere.
Functional activity. All neoplasms are classified in this chapter, whether they are functionally active or not. An additional code from Chapter 4 may be used, to identify functional activity associated with any neoplasm. Morphology [Histology]
In a few cases, such as for malignant melanoma and certain neuroendocrine tumors, the morphology (histologic type) is included in the category and codes. Primary malignant neoplasms overlapping site boundaries.